Bifogade filer
Mentice Interim Report 2024 Q1 EN
Kurs & Likviditet
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Mentice via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2024-05-03 08:30:00
Slower start of the year while ambition still in line with financial targets.
Significant events during the first quarter 2024 (Jan – Mar)
- Mentice has received a major repeat order from a world-leading medical technology company.
- Mentice performed its first Capital Market Day on March 21 in Stockholm.
- Mentice presented revised Financial Targets during the Capital Markets Day.
Financial targets
Growth
20-30% annual growth in net sales.
Profitability
To reach a 20% EBITDA margin within three years with a longer-term target of 30%.
FIRST QUARTER 2024 (JAN - MAR)
- Order intake amounted to 38 (58) MSEK, a decrease of -34.2%, of which -0.1% was related to the currency effect.
- The order book by the end of the period was 146.9 (126.2) MSEK, an increase of 16,4%.
- Net sales amounted to 45.3 (65.0) MSEK, a decrease of -30%, whereof -28% organic and -2% currency effect.
- Earnings before interest, tax, depreciation, and amortization (EBITDA) amounted to -18.4 (7.3) MSEK.
- Net income for the period amounted to -24.6 (-1.5) MSEK.
- Earnings per share (EPS) were -0.96 (-0.06) SEK.
- Cash flow from operating activities amounted to 1.9 (1.2) MSEK.
Webcast presentation of the interim report
To join the presentation, please visit https://investor.mentice.com.